Drug Houses of Australia (DHA) was originally established in 1936[1] as an amalgamation of seven Australian pharmaceutical companies, notably A. M. Bickford & Sons. In 1970, DHA was taken over by the British bank Slater Walker.[1]

Drug Houses of Australia is now a leading generic pharmaceutics and Chinese proprietary medicine (CPM) manufacturer based in Jurong, Singapore.

It was sold to Strides Arcolab through a share purchase agreement with Haw Par Healthcare Limited, Singapore in September 2006 for approximately SGD$19.7 million.

It is currently a part of Strides Arcolab which is listed on both the Indian stock exchanges Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).

References

  1. 1 2 Bickford's, SA Memory, State Library of South Australia
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.